TGFB1 and interstitial lung disease: Our study showed that the concentrations of KL-6, SP-D, and TGF-β1 are higher in patients with autoimmune-related ILD than in CTD patients without ILD, indicating their potential as biomarkers for the presence of lung fibrosis in these conditions.